Predisposed to doze: Promethazine, CYP2D6 poor metabolizer

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This case discusses a drug-gene interaction. Promethazine is a cytochrome P450 (CYP) 2D6 substrate. Patients who are CYP2D6 poor metabolizers exhibit greater sedation for a given promethazine dose.

Cite

CITATION STYLE

APA

Wittwer, E. D., Sprung, J., & Nicholson, W. T. (2015). Predisposed to doze: Promethazine, CYP2D6 poor metabolizer. In A Case Approach to Perioperative Drug-Drug Interactions (pp. 401–403). Springer New York. https://doi.org/10.1007/978-1-4614-7495-1_86

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free